arXiv:2603. 19186v3 Announce Type: replace Abstract: Randomized controlled trials (RCTs) are the gold standard for estimating treatment effects, yet they are often underpowered for detecting effect heterogeneity.
arXiv:2604. 23107v2 Announce Type: replace-cross Abstract: Causal effect estimation from observational data requires careful adjustment for confounding.
arXiv:2607. 10540v1 Announce Type: cross Abstract: We propose a two-stage estimator for structural mediation parameters that combines deep representation learning with G-estimation under the "no essential heterogeneity" (NEH) assumption.
arXiv:2607. 22762v1 Announce Type: cross Abstract: Causal inference has become a central issue across various fields, including computer science, statistics, economics, education, healthcare, and medicine.
arXiv:2609.38547v1 Announce Type: cross Abstract: Defining a weighted mean over probability measures under probability metrics is a central tool in probabilistic machine learning. Under the Wasserste...
arXiv:2607. 26599v1 Announce Type: new Abstract: Estimating heterogeneous treatment effects is central to targeted interventions, such as personalized promotions and precision medicine.
arXiv:2510. 21457v2 Announce Type: replace Abstract: Estimating heterogeneous treatment effects in network settings is complicated by interference, meaning that the outcome of an instance can be influenced by the treatment status of others.
arXiv:2608. 01352v1 Announce Type: new Abstract: Estimating causal effects from real-world spatiotemporal data is challenging due to hidden confounders and interference.
Estimating heterogeneous treatment effects is central to targeted interventions, such as personalized promotions and precision medicine. We focus on the conditional average treatment effect (CATE), a standard estimand for characterizing such heterogeneity.
arXiv:2606. 14734v1 Announce Type: cross Abstract: Motivation: Gene regulatory network inference from single-cell RNA sequencing (scRNA-seq) data is important for uncovering cell-state-specific transcriptional programs.
scDEFT is a deep learning framework that treats a drug as a conditioning operator on single‑cell representations, enabling prediction of drug‑induced state changes and responder status. The model learns drug‑conditioned cell latents via feature‑wise linear modulation, aggregates them over transcriptional neighborhoods, and ranks latent dimensions to identify genes distinguishing responders from non‑responders. Applied to a harmonized inflammatory bowel disease atlas of 1.16 million cells, scDEFT achieves 45% of the baseline‑to‑reproducibility ceiling in state‑change prediction and stratifies responders before treatment with an AUROC of 0.70, outperforming standard predictors.
arXiv:2606. 27114v1 Announce Type: new Abstract: Uplift modeling, crucial for estimating individual treatment effects (ITE), faces dual challenges: flexibly leveraging inter-group similarity to enhance discriminative power and debiasing under unobserved confounding scenarios.